Loss of p27(Kip1) expression correlates with tumor grade and with reduced disease-free survival in primary superficial bladder cancers

Cancer Research

Volumn 59, Issue 13, 1999, Pages 3245-3250

  Sgambato, Alessandro ^a   Migaldi, Mario ^b   Faraglia, Beatrice ^a   Garagnani, Lorella ^b   Romano, Gianpiero ^a   De Gaetani, Carmela ^b   Ferrari, Paolo ^c   Capelli, Giovanni ^a   Trentini, Gian Paolo ^b   Cittadini, Achille ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^c Universitaria di Modena   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P27; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1B; MICROTUBULE ASSOCIATED PROTEIN; PROTEIN P53; TUMOR SUPPRESSOR PROTEIN;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER GRADING; CANCER RECURRENCE; CANCER SURVIVAL; CORRELATION FUNCTION; DISEASE MARKER; DISEASE SEVERITY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; ONCOGENE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE; AGE; BLADDER TUMOR; CANCER STAGING; COHORT ANALYSIS; DISEASE FREE SURVIVAL; GENETICS; MIDDLE AGED; MORTALITY; PATHOLOGY; PREDICTION AND FORECASTING; SEX DIFFERENCE; SURVIVAL; TIME;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CELL CYCLE PROTEINS; COHORT STUDIES; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DISEASE-FREE SURVIVAL; FEMALE; GENES, TUMOR SUPPRESSOR; HUMANS; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SEX FACTORS; SURVIVAL ANALYSIS; TIME FACTORS; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS; URINARY BLADDER NEOPLASMS;

EID: 0033153763     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. MacLachlan, T. K., Sang, N., and Giordano, A. Cyclins, cyclin-dependent kinases and Cdk inhibitors: implications in cell cycle control and cancer. Crit. Rev. Eukaryot. Gene Expr., 5: 127-156, 1995.
2. Weinstein, I. B., and Zhou, P. Cell cycle control gene defects and human cancers. In: J. R. Bertino (ed.), Encyclopedia of Cancer, Vol. 1, pp. 256-267. New York: Academic Press, 1997.
3. INK4/MTS2_ related CDK6 inhibitor, correlates with wild-type Rb function. Genes Dev., 8: 2939-2952, 1994.
4. INK4B1. Cancer Res., 56: 722-727, 1996.
5. Serrano, M., Lee, H-W., Chin, L., Cordon-Cardo, C., Beach, D., and Depinto, R. A. Role of the INK4a locus in tumor suppression and cell mortality. Cell, 85: 27-37, 1996.
6. Kip1, to regions involved in human cancer. Cancer Res., 55: 1199-1205, 1995.
7. Kip1 in primary breast carcinomas. Hum. Genet., 97: 91-94, 1996.
8. Kawamata, N., Morosetti, R., Miller, C. W., Park, D., Spirin, K. S., Nakamaki, T., Takeuchi, S., Hatta, Y., Simpson, J., Wilczynski, S., Lee, Y. Y., Bartram, C. R., and Koeffler, H. P. Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in human malignancies. Cancer Res., 55: 2266-2269, 1995.
9. Kip1 gene in non-Hodgkin's lymphomas and adult T-cell leukemia/lymphoma. Blood, 86: 1924-1930, 1995.
10. Pietenpol, J. A., Bohlander, S. K., Sato, Y., Papadopoulos, N., Liu, B., Friedman, C., Trask, B. J., Roberts, J. M., Kinzler, K. W., Rowley, J. D., and Vogelstein, B. Assignment of the human p27Kip1 gene to 12p13 and its analysis in leukemias. Cancer Res., 55: 1206-1210, 1995.
11. Kip1: chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumors. Cancer Res., 55: 1211-1214, 1995.
12. Shiohara, M., El-Deiry, W. S., Wada, M., Nakamaki, T., Takeuchi, S., Yang, R., Chen, D-L., Vogelstein, B., and Koeffler, H. P. Absence of WAF1 mutations in a variety of human malignancies. Blood, 84: 3781-3784, 1994.
13. Spirin, K. S., Simpson, J. F., Takeuchi, S., Kawamata, N., Miller, C. W., and Koeffler, H. P. p27/Kip1 mutations found in breast cancer. Cancer Res., 56: 2400-2404, 1996.
14. Kip1 protein: prognostic implications in primary breast cancer. Nat. Med., 3: 227-230, 1997.
15. Esposito, V., Baldi, A., De Luca, A., Groger, A. M., Loda, M., Giordano, G. G., Caputi, M., Baldi, F., Pagano, M., and Giordano, A. Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer. Cancer Res., 57: 3381-3385, 1997.
16. Loda, M., Cukor, B., Tam, S. W., Lavin, P., Fiorentino, M., Draetta, G. F., Jessup, J. M., and Pagano, M. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nat. Med., 3: 231-233, 1997.
17. Porter, P. L., Malone, K. E., Heagerty, P. J., Alexander, G. M., Gatti, L. A., Firpo, E. L. Daling, J. R., and Roberts, J. M. Expression of cell-cycle regulators p27 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nat. Med., 3: 222-225, 1997.
18. Kip1 is a novel prognostic factor in localized human prostate adenocarcinoma. Cancer Res., 58: 542-548, 1998.
19. Lane, D. P. p53, guardian of the genome. Nature (Lond.), 358: 15-16, 1992.
20. Momand, J., Zambetti, G. P., Olson, D. C., George, D., and Levine, A. J. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell, 26: 1237-1245, 1992.
21. Esrig, D., Spruck, C. H., Nichols, P., Chaiwun, B., Steven, K., Groshen, S., Chen, S. C., Skinner, D. G., Jones, P. A., and Cote, R. J. p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade and stage in bladder cancer. Am. J. Pathol., 143: 1389-1397, 1993.
22. Sarkis, A. S., Dalbagni, G., Cordon-Cardo, C., Zhang, Z. F., Sheinfeld, J., Fair, W. R., Herr, H. W., and Reuter, V. E. Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: a marker for disease progression. J. Natl. Cancer Inst., 85: 53-59, 1993.
23. Mostofi, F. H., Sobin, L. H., and Torloni, H. Histological typing of urinary bladder tumors. In: International Classification of Tumors, No. 10. Geneva: World Health Organization, 1973.
24. Sobin, L. H., and Wittekind, C. TNM Classification of Malignant Tumors, Ed. 5. New York: Wiley-Liss, 1997.
25. Lipponen, P. K. Over-expression of p53 nuclear oncoprotein in transitional-cell bladder cancer and its prognostic value. Int. J. Cancer, 53: 365-370, 1993.
26. Serth, J., Kuczyk, M. A., Bokemeyer, C., Hervatin, C., Nafe, R., Tan, H. K., and Jonas, U. p53 immunohistochemistry as an independent prognostic factor for superficial transitional cell carcinoma of the bladder. Br. J. Cancer, 71: 201-205, 1995.
27. Fleiss, J. L. Statistical methods for rates and proportions, Ed. 2. New York: John Wiley and sons, 1981.
28. Pagano, M., Tam, S. W., Theodoras, A. M., Beer-Romero, P., Del Sal, G., Chau, V., Yew, P. R., Draetta, G. F., and Rolfe, M. Role of the Ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science (Washington DC), 269: 682-685, 1995.
29. 1 arrest. Cell, 76: 1013-1023, 1994.
30. El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., and Vogelstein, B. WAF1, a potential mediator of p53 tumor suppression. Cell. 75: 817-825, 1993.
31. KIP1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell, 78: 59-66, 1994.
32. 1 cyclin-dependent kinases. Genes and Dev., 9: 1149-1163, 1995.
33. Bartkova, J., Lukas, J., Muller, H., Lutzhoft, D., Strauss, M., and Bartek, J. Cyclin D1 protein expression and function in human breast cancer. Int. J. Cancer, 57: 353-361, 1994.
34. Jiang, W., Zhang, Y-J., Kahn, S. M., Hollestein, M. C., Santella, R. M., Lu, S. H., Harris, C. C., Montesano, R., and Weinstein, I. B. Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer. Proc. Natl. Acad. Sci. USA, 90: 9026-9030, 1993.
35. Aagaard, L., Lukas, J., Bartkova, J., Kjerulff, A. A., Strauss, M., and Bartek, J. Aberrations of p16Ink4 and retinoblastoma tumor-suppressor gene occur in distinct sub-sets of human cancer cell lines. Int. J. Cancer, 61: 115-120, 1995.
36. INK4 expression in primary lung cancer and cell lines. Cancer Res., 55: 505-509, 1995.
37. Lane, D. P., and Hall, P. A. MDM2-arbiter of p53's destruction. Trends Biochem. Sci. 22: 372-374, 1997.
38. Scheffner, M., Huibregtse, J. M., Vierstra, R. D., and Howley, P. M. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquination of p53. Cell, 75: 495-505, 1993.
39. Gardiner, R. A., Walsh, M. D., Allen, V., Rahman, S., Samaratunga, M. L. T. H., Seymour, G. J., and Lavin, M. F. Immunohistological expression of p53 in primary pT1 transitional cell bladder cancer in relation to tumour progression. Br. J. Urol., 73: 526-532, 1994.
40. Nakopoulou, L., Constantimdes, C., Papandropoulos, J., Theodoropoulos, G., Tzonou, A., Giannopoulos, A., Zervas, A., and Dimopoulos, C. Evaluation of overexpression of p53 tumor suppressor protein in superficial and invasive transitional cell bladder cancer: comparison with DNA ploidy. Urology, 46: 334-340, 1995.
41. Kip1 in human breast cancers. Clin. Cancer Res., 3: 1879-1887, 1997.
42. Kip1 and degree of malignancy in human breast and colorectal cancers. Proc. Natl. Acad. Sci. USA, 94: 6380-6385, 1997.
43. Kip1 in multistage colorectal carcinogenesis. Cancer Res., 58: 114-122, 1997.
44. kip1 protein in human esophageal cancer cell lines that overexpress cyclin D1. Carcinogenesis (Lond.), 18: 1139-1148, 1997.
45. Kitahara, K., Yasui, W., Yokozaki, H., Semba, S., Hamamoto, T., Hisatsugu, T., and Tahara, E. Expression of cyclin D1, CDK4 and p27Kip1 is associated with the p16MTS1 gene status in human esophageal carcinoma cell lines. J. Exp. Ther. Oncol. 1: 7-12, 1996.
46. Shin, K. Y., Kong, G., Kim, W. S., Lee, T. Y., Woo, Y. N., and Lee, J. D. Overexpression of cyclin D1 correlates with early recurrence in superficial bladder cancers. Br. J. Cancer, 75: 1788-1792, 1997.
47. Boring, C. C., Squires, T. S., and Tong T. Cancer Statistics, 1994. CA Cancer J. Clin., 44: 7-26, 1994.